Champions Oncology, Inc. Profile Avatar - Palmy Investing

Champions Oncology, Inc.

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the imp…

Biotechnology
US, Hackensack [HQ]

Insiders

Transactions

Track non-derivative insider transactions.
i = Indirect d = Direct cs = Common Stock
Reported Owner(s) Position Now Transaction Date Type Position Change Extra
Ackerman Joel
Director
$962,134 d cs
10% Holder
10/31/24
M
16,667 x $5.43 = $90,501.81
Ackerman Joel
Director
$945,467 d cs
10% Holder
10/31/24
M
88,470 x $2.10 = $185,787.00
Mendelson Daniel Newman
Director
$198,625 d cs
10% Holder
01/12/24
P
1,000 x $6.50 = $6,500.00
Mendelson Daniel Newman
Director
$197,625 d cs
10% Holder
01/11/24
P
2,000 x $6.27 = $12,540.00
Mendelson Daniel Newman
Director
$195,625 d cs
10% Holder
01/10/24
P
2,944 x $6.31 = $18,576.64

Get PRO Today

With PRO you will unlock 30 more insider transactions for Champions Oncology, Inc.

Statistics
Sample Size: 35 Transactions
Sale (S)
0
0.00%
Buy (P)
87,886
74.29%
25.71%
Other Ownership

Individuals

We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture: